Detalhe da pesquisa
1.
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration.
Nature
; 562(7728): 605-609, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333625
2.
Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 199(2): 381-387, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995492
3.
Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.
Ann Surg Oncol
; 28(6): 3383-3393, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32996020
4.
Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology.
Cancer
; 126(8): 1605-1613, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31967687
5.
Effect of Doxorubicin on Myocardial Bicarbonate Production From Pyruvate Dehydrogenase in Women With Breast Cancer.
Circ Res
; 127(12): 1568-1570, 2020 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054563
6.
Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions.
Transfusion
; 54(1): 98-103, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23711236
7.
A Tale of Two Hospitals: Effect of Access to Care Through a Safety Net Hospital on Adjuvant Therapy, Imaging Compliance and 5-Year Survival Rates Compared to the University Hospital Served by the Same Breast Cancer Clinical Teams.
Acad Radiol
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365491
8.
Mapping Cellular Interactions from Spatially Resolved Transcriptomics Data.
bioRxiv
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781617
9.
Diagnostic accuracy of diffuse reflectance imaging for early detection of pre-malignant and malignant changes in the oral cavity: a feasibility study.
BMC Cancer
; 13: 278, 2013 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23738507
10.
The Utility of Breast Cancer Index (BCI) Over Clinical Prognostic Tools for Predicting the Need for Extended Endocrine Therapy: A Safety Net Hospital Experience.
Clin Breast Cancer
; 22(8): 823-827, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089460
11.
A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.
Clin Breast Cancer
; 21(5): 417-424, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836974
12.
The Changing Paradigm for the Treatment of HER2-Positive Breast Cancer.
Cancers (Basel)
; 12(8)2020 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731409
13.
An evaluation of fulvestrant for the treatment of metastatic breast cancer.
Expert Opin Pharmacother
; 20(15): 1819-1829, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486688
14.
Neratinib: Inching Up on the Cure Rate of HER2+ Breast Cancer?
Clin Cancer Res
; 24(15): 3483-3485, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29802101
15.
Is Dual mTORC1 and mTORC2 Therapeutic Blockade Clinically Feasible in Cancer?
JAMA Oncol
; 5(11): 1564-1565, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465107
16.
Correction: Neratinib: Inching Up on the Cure Rate of HER2+ Breast Cancer?
Clin Cancer Res
; 25(4): 1430, 2019 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770489
17.
A new class of agents for estrogen-receptor-positive breast cancer.
Expert Rev Clin Pharmacol
; 11(4): 325-328, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439601